Research & Policy

Corporate stories about Research & Policy across 3BL's network.

Latest in Research & Policy

Novartis Expands Partnership with Medicines for Malaria Venture to Develop Next-Generation Antimalarial Treatment
Novartis announced today that it will further expand its long-standing partnership with Medicines for Malaria Venture (MMV).
A ’Close’-Up Look at Diabetes In Cities
With many years of personal and professional experience in the diabetes field, patient advocate Kelly Close and her colleague Emily Regier from Close Concerns offer their perspective on Cities Changing Diabetes1.
CleanMed – Health Care and Sustainability Nirvana
I fell in love with the CleanMed conference when I first attended in 2010. CleanMed is a content-rich gathering, chock full of heart. It was started by two determined nonprofits, Healthcare without Harm andPractice Greenhealth, in 2001.
A Golden Opportunity to Change Diabetes in Johannesburg
In 1886 a large gold reef was discovered on a remote African farm setting off a major gold rush that led to the establishment of Johannesburg. As the news spread, the population of the city exploded with people hoping to find the riches and Johannesburg quickly became the largest city in South Africa.1 In fact, the Zulu name for Johannesburg is Egoli which means City of Gold.
GRI
GRI Podcasts: Beyond Peports - Episode 2, Dr. Nelmara Arbex
This month Nelmara Arbex talks about the initial findings of the Sustainability and Reporting 2025 project in the new GRI publication "The Next Era of Corporate Disclosure: Digital, Responsible, Interactive".
Putting the Cook Back in the Urban Kitchen
Preparing meals at home can be challenging for the millions living in cities. Everything from long work days to cheap and convenient fast food options makes choosing to cook fresh and balanced meals difficult. But these dietary choices are also contributing to the rise of type 2 diabetes in cities around the world.
More than 750 Million Anti Malaria Treatments for Adults and Children Provided Without Profit
Today is World Malaria Day. Malaria is preventable and curable, yet it is still one of the most deadly diseases in developing countries. Despite extraordinary progress in the fight against malaria over the last 15 years, the disease still claims the life of a child every two minutes. Since 2001, working with a range of organizations, the Novartis Malaria Initiative – one of the pharmaceutical industry’s largest access-to-medicine programs – has provided more than 750 million treatments for adults and children, without profit, to more than 60 countries, contributing to a dramatic reduction of malaria deaths in Africa.
Experts Discuss Better Treatments Against Parasitic Diseases
On April 4-8 2016, the Novartis Institute for Tropical Diseases (NITD) held a Symposium on Parasitology in Lusaka, Zambia, bringing together international and local experts in the field with the aim of engaging in productive scientific exchange on parasitic diseases - including malaria, sleeping sickness (Human African Trypanosomiasis), Chagas, leishmaniasis, and cryptosporidiosis. Experts engaged in discussions over target product profiles for these diseases and shared the latest accomplishments in drug discovery and cutting edge basic research that will potentially enable the delivery of novel drug candidates with the adequate pharmacological profiles.
National Recognition for Art Therapy through AATA's Partnership with Americans for the Arts
On March 7 & 8, 2016, AATA Executive Director Cynthia Woodruff, and President Dr. Donna Betts, ATR-BC, represented the American Art Therapy Association (AATA) at the Arts Advocacy Day National Arts Action Summit. This annual event provides attendees with advocacy training and an opportunity to attend coordinated visits with Members of Congress. Hosted by Americans for the Arts in partnership with over 85 national arts-related organizations, Arts Advocacy Day is the largest gathering of its kind, bringing together a broad variety of the nation’s civic and cultural groups. Grassroots advocates from across the country came to Washington to garner support for issues related to funding for the National Endowment for the Arts (NEA), arts education policy, and more.